Comparison

EGFR-IN-2 European Partner

Item no. TMO-T11159-100mg
Manufacturer TargetMol
CASRN 1643497-70-4
Amount 100 mg
Quantity options 100 mg 10 mg 1 mg 25 mg 500 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Smiles [C@@H](CC)(C)N1N=C(C=2C1=CC(NC3=NC(=NC=C3)C4=CN(S(=O)(=O)C5CC5)N=C4)=NC2)N6CC(C(C)(C)O)C6
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias 1643497-70-4
Shipping Condition Cool pack
Available
Manufacturer - Targets
EGFR
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
551.66
Description
EGFR-IN-2 is a non-covalent, orally available and mutation-selective EGFR inhibitor for the treatment of non-small cell lung cancer (NSCLC), with high selectivity for resistant single and double mutant T790M with IC50 = 27 nm to 33 nM, and low inhibitory activity for wild-type H292 (IC50 = 218 nM).
Pathways
Tyrosine Kinase/Adaptors|||JAK/STAT signaling|||Angiogenesis

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?